AbbVie’s $63 Billion Mega Deal Returns Focus to Debt-Fueled M&A

Bookmark
(Bloomberg) -- AbbVie Inc.’s $63 billion deal for Allergan Plc will take the company’s debt burden to a level that can rival some junk-rated companies.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.